India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact
India’s Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have signed an exclusive licensing agreement for IGI’s cancer treatment, adding to …